EP1569928A4 - Composes et methodes therapeutiques - Google Patents

Composes et methodes therapeutiques

Info

Publication number
EP1569928A4
EP1569928A4 EP03769069A EP03769069A EP1569928A4 EP 1569928 A4 EP1569928 A4 EP 1569928A4 EP 03769069 A EP03769069 A EP 03769069A EP 03769069 A EP03769069 A EP 03769069A EP 1569928 A4 EP1569928 A4 EP 1569928A4
Authority
EP
European Patent Office
Prior art keywords
methods
therapeutic compounds
therapeutic
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03769069A
Other languages
German (de)
English (en)
Other versions
EP1569928A1 (fr
Inventor
Barbara Martha Meurer-Grimes
Jin Yu
Gino Luigi Vairo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sarawak Government of State of Malaysia
Original Assignee
Sarawak Government of State of Malaysia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/291,863 external-priority patent/US6710075B2/en
Application filed by Sarawak Government of State of Malaysia filed Critical Sarawak Government of State of Malaysia
Publication of EP1569928A1 publication Critical patent/EP1569928A1/fr
Publication of EP1569928A4 publication Critical patent/EP1569928A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
EP03769069A 2002-11-08 2003-11-06 Composes et methodes therapeutiques Withdrawn EP1569928A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/291,863 US6710075B2 (en) 2000-07-05 2002-11-08 Therapeutic compounds and methods
US291863 2002-11-08
PCT/AU2003/001463 WO2004041812A1 (fr) 2002-11-08 2003-11-06 Composes et methodes therapeutiques

Publications (2)

Publication Number Publication Date
EP1569928A1 EP1569928A1 (fr) 2005-09-07
EP1569928A4 true EP1569928A4 (fr) 2008-12-10

Family

ID=32312131

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03769069A Withdrawn EP1569928A4 (fr) 2002-11-08 2003-11-06 Composes et methodes therapeutiques

Country Status (5)

Country Link
EP (1) EP1569928A4 (fr)
JP (1) JP4847014B2 (fr)
AU (1) AU2003277988A1 (fr)
CA (1) CA2504999A1 (fr)
WO (1) WO2004041812A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5249508B2 (ja) 2006-11-06 2013-07-31 三菱重工業株式会社 軌道系交通システム
EP2722042B1 (fr) 2011-06-16 2019-05-29 Korea Research Institute of Chemical Technology Dérivés indanone, leurs isomères optiques ou leurs sels pharmaceutiquement acceptables, leur procédé de préparation, et des compositions pharmaceutiques les contenant en tant que principe actif pour prévenir ou traiter des maladies virales
PT3882244T (pt) 2012-12-14 2025-04-04 Univ Leuven Kath Composto, sal farmaceuticamente aceitável ou isómero ótico do mesmo, método para a sua preparação e composição farmacêutica para prevenção ou tratamento de doenças virais que contenha o mesmo como ingrediente ativo
US10639378B2 (en) 2016-06-06 2020-05-05 Genentech, Inc. Silvestrol antibody-drug conjugates and methods of use
KR102894005B1 (ko) 2020-04-20 2025-12-03 노파르티스 아게 항바이러스 1,3-다이-옥소-인덴 화합물
CN115916763B (zh) 2020-04-20 2025-06-03 诺华股份有限公司 抗病毒素1,3-二氧代茚化合物
CN115385924B (zh) * 2022-10-06 2023-10-13 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) 一种具有抗肿瘤活性的环戊烷苯并呋喃类化合物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19835325A1 (de) * 1998-08-05 2000-02-10 Bayer Ag Verwendung von Cyclopentabenzofuran-Derivaten zur Bekämpfung von NF-kB abhängigen Krankheiten
AUPQ866500A0 (en) * 2000-07-05 2000-08-03 Exgenix Operations Pty Ltd Therapeutic compounds and methods

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number Publication date
JP2006508098A (ja) 2006-03-09
EP1569928A1 (fr) 2005-09-07
CA2504999A1 (fr) 2004-05-21
WO2004041812A1 (fr) 2004-05-21
AU2003277988A1 (en) 2004-06-07
JP4847014B2 (ja) 2011-12-28

Similar Documents

Publication Publication Date Title
GB0206876D0 (en) Therapeutic agents
GB0209991D0 (en) Therapeutic agents
GB0209995D0 (en) Therapeutic agents
GB0209997D0 (en) Therapeutic agents
GB0210127D0 (en) Therapeutic agents
EP1575495A4 (fr) Composes et procedes
GB0223349D0 (en) Therapeutic agents
GB0210124D0 (en) Therapeutic agents
EP1682136A4 (fr) Composes therapeutiques et utilisations correspondantes
GB0219660D0 (en) Therapeutic use
GB0218876D0 (en) Therapeutic agents
GB0207410D0 (en) Compounds and their therapeutic use
GB0308382D0 (en) Therapeutic methods and means
PL397022A1 (pl) Środek leczniczy
GB0210741D0 (en) Methods of therapy
GB0225501D0 (en) Therapeutic agents
GB0208394D0 (en) Therapeutic agents
GB0226462D0 (en) Therapeutic agents
GB0217068D0 (en) Therapeutic agents
GB0207409D0 (en) Benzofuran-2H-3-one compounds and their therapeutic use
AU2003231937A8 (en) Therapeutic methods
GB0305699D0 (en) Therapeutic compositions and methods
AU2003223357A8 (en) Compounds and methods
GB0213383D0 (en) Therapeutic conditions
GB0209039D0 (en) Therapeutic methods and means

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050608

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1080084

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20081111

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20081230

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1080084

Country of ref document: HK